HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Daniel Erskine Selected Research
Daniel Erskine Research Topics
Disease
11
Parkinson Disease (Parkinson's Disease)
08/2023 - 01/2019
10
Dementia (Dementias)
12/2022 - 06/2017
6
Synucleinopathies
01/2022 - 01/2019
4
Lewy Body Disease (Lewy Body Dementia)
12/2022 - 12/2019
3
Cognitive Dysfunction
01/2022 - 09/2017
3
Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2017
2
Mitochondrial Diseases (Mitochondrial Disease)
06/2023 - 01/2023
2
Gliosis
01/2023 - 01/2016
2
Diffuse Cerebral Sclerosis of Schilder (Alpers' Disease)
01/2023 - 10/2022
2
Neurodegenerative Diseases (Neurodegenerative Disease)
10/2022 - 01/2022
2
Multiple System Atrophy
01/2020 - 01/2019
2
Hallucinations (Hallucination)
06/2017 - 01/2016
1
Drug Resistant Epilepsy
01/2023
1
Neurologic Manifestations (Neurological Manifestations)
01/2023
1
Sudden Unexpected Death in Epilepsy
10/2022
1
Epilepsy (Aura)
10/2022
1
Globoid Cell Leukodystrophy (Krabbe Disease)
01/2022
1
Sensorineural Hearing Loss
01/2022
1
Neuroinflammatory Diseases
01/2022
1
Status Epilepticus (Complex Partial Status Epilepticus)
01/2022
1
Atrophy
01/2022
1
Stroke (Strokes)
01/2022
1
Inflammation (Inflammations)
01/2022
1
Hypertension (High Blood Pressure)
12/2021
1
Rare Diseases (Rare Disease)
10/2021
1
Disease Progression
01/2021
1
Schizophrenia (Dementia Praecox)
12/2019
1
Nervous System Diseases (Neurological Disorders)
12/2019
1
Mental Disorders (Mental Disorder)
12/2019
1
Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2019
1
Demyelinating Diseases (Demyelinating Disease)
01/2019
1
Wallerian Degeneration
09/2017
Drug/Important Bio-Agent (IBA)
14
Synucleins
IBA
12/2022 - 06/2017
9
Proteins (Proteins, Gene)
FDA Link
08/2023 - 09/2017
5
Biomarkers (Surrogate Marker)
IBA
11/2022 - 09/2017
4
Antibodies
IBA
01/2022 - 01/2019
3
Mitochondrial DNA (mtDNA)
IBA
01/2023 - 01/2022
2
Serine (L-Serine)
FDA Link
12/2022 - 01/2020
2
Amyloid (Amyloid Fibrils)
IBA
01/2019 - 01/2016
1
Glial Fibrillary Acidic Protein
IBA
01/2023
1
Calbindin 2
IBA
10/2022
1
Parvalbumins
IBA
10/2022
1
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
10/2022
1
Calbindins
IBA
10/2022
1
Single-Domain Antibodies
IBA
01/2022
1
Prions
IBA
01/2022
1
Psychosine (Galactosylsphingosine)
IBA
01/2022
1
Messenger RNA (mRNA)
IBA
01/2022
1
Sphingolipids
IBA
01/2022
1
Lactic Acid (Lactate)
FDA Link
Generic
01/2022
1
Antigens
IBA
01/2022
1
alpha-Synuclein
IBA
01/2022
1
Apolipoproteins E (ApoE)
IBA
12/2021
1
Monoclonal Antibodies
IBA
01/2020
1
Epitopes
IBA
01/2020
1
Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
IBA
12/2019
1
Cholinergic Agents (Cholinergics)
IBA
12/2019
1
Blood Proteins (Serum Proteins)
IBA
01/2019
1
Fibrinogen (Factor I)
FDA Link
01/2019
1
Peptide Hydrolases (Proteases)
FDA Link
09/2017
1
Myelin-Associated Glycoprotein
IBA
09/2017
1
Calpain
IBA
09/2017
1
DNA (Deoxyribonucleic Acid)
IBA
01/2017
1
Retinaldehyde (Retinal)
IBA
01/2016
Therapy/Procedure
4
Therapeutics
06/2023 - 01/2019
1
Immunotherapy
01/2020